Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemia.
We report the first documented case of the use of peripheral blood stem cell autografting in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. This case illustrates the complex ethical and clinical issues that arise in the treatment of such patients.
Kerridge
I
I
Health Law and Ethics Program, University of Newcastle, Australia.
Lowe
M
M
Seldon
M
M
Enno
A
A
Deveridge
S
S
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002835:Christianity; D004992:Ethics, Medical; D006801:Humans; D033221:Jehovah's Witnesses; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy*; D007958:Leukocyte Count; D008297:Male; D033242:Minors; D026684:Personal Autonomy; D010976:Platelet Count; D012074:Remission Induction